|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
Statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Giraldi G, Martinoli L and De Lucad'
Alessandro E: The human papillomavirus vaccination: A review of the
cost-effectiveness studies. Clin Ter. 165:e426–e432.
2014.PubMed/NCBI
|
|
4
|
Yang SH, Kong SK, Lee SH, Lim SY and Park
CY: Human papillomavirus 18 as a poor prognostic factor in stage
I–IIA cervical cancer following primary surgical treatment. Obstet
Gynecol Sci. 57:492–500. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ludmir EB, Palta M, Zhang X, Wu Y, Willett
CG and Czito BG: Incidence and prognostic impact of high-risk HPV
tumor infection in cervical esophageal carcinoma. J Gastrointest
Oncol. 5:401–407. 2014.PubMed/NCBI
|
|
6
|
Buitrago-Pérez A, Garaulet G,
Vázquez-Carballo A, Paramio JM and García-Escudero R: Molecular
signature of HPV-induced carcinogenesis: pRb, p53 and gene
expression profiling. Curr Genomics. 10:26–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saha SK and Khuda-Bukhsh AR: Berberine
alters epigenetic modifications, disrupts microtubule network, and
modulates HPV-18 E6-E7 oncoproteins by targeting p53 in cervical
cancer cell HeLa: A mechanistic study including molecular docking.
Eur J Pharmacol. 744:132–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jaiswal N, John R, Chand V and Nag A:
Oncogenic human papillomavirus 16E7 modulates SUMOylation of
FOXM1b. Int J Biochem Cell Biol. 58:28–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang C, Qiu Z, Wang L, Peng Z, Jia Z,
Logsdon CD, Le X, Wei D, Huang S and Xie K: A novel FOXM1-caveolin
signaling pathway promotes pancreatic cancer invasion and
metastasis. Cancer Res. 72:655–665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Visnovsky J, Kudela E, Farkasova A,
Balharek T, Krkoska M and Danko J: Amplification of TERT and TERC
genes in cervical intraepithelial neoplasia and cervical cancer.
Neuro Endocrinol Lett. 35:518–522. 2014.PubMed/NCBI
|
|
11
|
Halasi M, Pandit B, Wang M, Nogueira V,
Hay N and Gartel AL: Combination of oxidative stress and FOXM1
inhibitors induces apoptosis in cancer cells and inhibits xenograft
tumor growth. Am J Pathol. 183:257–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Laoukili J, Stahl M and Medema RH: FOXM1:
At the crossroads of ageing and cancer. Biochim Biophys Acta.
1775:92–102. 2007.PubMed/NCBI
|
|
13
|
Zhao F, Siu MK, Jiang L, Tam KF, Ngan HY,
Le XF, Wong OG, Wong ES, Gomes AR, Bella L, et al: Overexpression
of forkhead box protein M1 (FOXM1) in ovarian cancer correlates
with poor patient survival and contributes to paclitaxel
resistance. PLoS One. 9:e1134782014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khongkow P, Karunarathna U, Khongkow M,
Gong C, Gomes AR, Yagüe E, Monteiro LJ, Kongsema M, Zona S, Man EP,
et al: FOXM1 targets NBS1 to regulate DNA damage-induced senescence
and epirubicin resistance. Oncogene. 33:4144–4155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bergamaschi A, MadakErdogan Z, Kim YJ,
Choi YL, Lu H and Katzenellenbogen BS: The forkhead transcription
factor FOXM1 promotes endocrine resistance and invasiveness in
estrogen receptor-positive breast cancer by expansion of stem-like
cancer cells. Breast Cancer Res. 16:4362014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang L, Wang P, Chen L and Chen H:
Down-regulation of FOXM1 by thiostrepton or small interfering RNA
inhibits proliferation, transformation ability and angiogenesis,
and induces apoptosis of nasopharyngeal carcinoma cells. Int J Clin
Exp Pathol. 7:5450–5460. 2014.PubMed/NCBI
|
|
17
|
Inoguchi S, Seki N, Chiyomaru T, Ishihara
T, Matsushita R, Mataki H, Itesako T, Tatarano S, Yoshino H, Goto
Y, et al: Tumour-suppressive microRNA-24-1 inhibits cancer cell
proliferation through targeting FOXM1 in bladder cancer. FEBS Lett.
588:3170–3179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen H, Zou Y, Yang H, Wang J and Pan H:
Downregulation of FOXM1 inhibits proliferation, invasion and
angiogenesis of HeLa cells in vitro and in vivo. Int J Oncol.
45:2355–2364. 2014.PubMed/NCBI
|
|
19
|
Guan P, Chen H, Li HJ, Duan J and Chen JY:
Expression and significance of FOXM1 in human cervical cancer: A
tissue micro-array study. Clin Invest Med. 34:E1–E7.
2011.PubMed/NCBI
|
|
20
|
Chan DW, Yu SY, Chiu PM, Yao KM, Liu VW,
Cheung AN and Ngan HY: Over-expression of FOXM1 transcription
factor is associated with cervical cancer progression and
pathogenesis. J Pathol. 215:245–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He SY, Shen HW, Xu L, Zhao XH, Yuan L, Niu
G, You ZS and Yao SZ: FOXM1 promotes tumor cell invasion and
correlates with poor prognosis in early-stage cervical cancer.
Gynecol Oncol. 127:601–610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Teh MT, Wong ST, Neill GW, Ghali LR,
Philpott MP and Quinn AG: FOXM1 is a downstream target of GLI1 in
basal cell carcinomas. Cancer Res. 62:4773–4780. 2002.PubMed/NCBI
|
|
23
|
Huang C, Du J and Xie K: FOXM1 and its
oncogenic signaling in pancreatic cancer pathogenesis. Biochim
Biophys Acta. 1845:104–116. 2014.PubMed/NCBI
|
|
24
|
Katoh Y and Katoh M: Hedgehog target
genes: Mechanisms of carcinogenesis induced by aberrant hedgehog
signaling activation. Curr Mol Med. 9:873–886. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shigemura K and Fujisawa M: Hedgehog
signaling and urological cancers. Curr Drug Targets. 16:258–271.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nüsslein-Volhard C and Wieschaus E:
Mutations affecting segment number and polarity in Drosophila.
Nature. 287:795–801. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Varjosalo M and Taipale J: Hedgehog:
Functions and mechanisms. Genes Dev. 22:2454–2472. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hooper JE and Scott MP: Communicating with
Hedgehogs. Nat Rev Mol Cell Biol. 6:306–317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang J and Hui CC: Hedgehog signaling in
development and cancer. Dev Cell. 15:801–812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Laurendeau I, Ferrer M, Garrido D, D'Haene
N, Ciavarelli P, Basso A, Vidaud M, Bieche I, Salmon I and Szijan
I: Gene expression profiling of the hedgehog signaling pathway in
human meningiomas. Mol Med. 16:262–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rimkus TK, Carpenter RL, Qasem S, Chan M
and Lo HW: Targeting the sonic hedgehog signaling pathway: Review
of smoothened and GLI inhibitors. Cancers (Basel). 8:E222016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Callahan BP and Wang C: Hedgehog
cholesterolysis: Specialized gatekeeper to oncogenic signaling.
Cancers (Basel). 7:2037–2053. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rovida E and Stecca B: Mitogen-activated
protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk
providing therapeutic opportunities? Semin Cancer Biol. 35:154–167.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mathew E, Zhang Y, Holtz AM, Kane KT, Song
JY, Allen BL and di Magliano M Pasca: Dosage-dependent regulation
of pancreatic cancer growth and angiogenesis by hedgehog signaling.
Cell Reports. 9:484–494. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fan D, Wang Y, Qi P, Chen Y, Xu P, Yang X,
Jin X and Tian X: MicroRNA-183 functions as the tumor suppressor
via inhibiting cellular invasion and metastasis by targeting MMP-9
in cervical cancer. Gynecol Oncol. S0090-8258(16): 300322016.(Epub
ahead of print).
|
|
36
|
Halasi M and Gartel AL: FOX(M1) news - it
is cancer. Mol Cancer Ther. 12:245–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kalin TV, Ustiyan V and Kalinichenko VV:
Multiple faces of FOXM1 transcription factor: Lessons from
transgenic mouse models. Cell Cycle. 10:396–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shin K, Lim A, Zhao C, Sahoo D, Pan Y,
Spiekerkoetter E, Liao JC and Beachy PA: Hedgehog signaling
restrains bladder cancer progression by eliciting stromal
production of urothelial differentiation factors. Cancer Cell.
26:521–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sabol M, Trnski D, Uzarevic Z, Ozretic P,
Musani V, Rafaj M, Cindric M and Levanat S: Combination of
cyclopamine and tamoxifen promotes survival and migration of mcf-7
breast cancer cells - interaction of hedgehog-gli and estrogen
receptor signaling pathways. PLoS One. 9:e1145102014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kai K, Aishima S and Miyazaki K:
Gallbladder cancer: Clinical and pathological approach. World J
Clin Cases. 2:515–521. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xuan YH, Jung HS, Choi YL, Shin YK, Kim
HJ, Kim KH, Kim WJ, Lee YJ and Kim SH: Enhanced expression of
hedgehog signaling molecules in squamous cell carcinoma of uterine
cervix and its precursor lesions. Mod Pathol. 19:1139–1147.
2006.PubMed/NCBI
|
|
42
|
Samarzija I and Beard P: Hedgehog pathway
regulators influence cervical cancer cell proliferation, survival
and migration. Biochem Biophys Res Commun. 425:64–69. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Koo CY, Muir KW and Lam EW: FOXM1: From
cancer initiation to progression and treatment. Biochim Biophys
Acta. 1819:28–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Laoukili J, Alvarez M, Meijer LA, Stahl M,
Mohammed S, Kleij L, Heck AJ and Medema RH: Activation of FOXM1
during G2 requires cyclin A/Cdk-dependent relief of autorepression
by the FOXM1 N-terminal domain. Mol Cell Biol. 28:3076–3087. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wierstra I: Cyclin D1/Cdk4 increases the
transcriptional activity of FOXM1c without phosphorylating FOXM1c.
Biochem Biophys Res Commun. 431:753–759. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xue J, Zhou A, Tan C, Wu Y, Lee HT, Li W,
Xie K and Huang S: Forkhead box M1 is essential for nuclear
localization of glioma-associated oncogene homolog 1 in
glioblastoma multiforme cells by promoting importin-7 expression. J
Biol Chem. 290:18662–18670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pignot G, Vieillefond A, Vacher S, Zerbib
M, Debre B, Lidereau R, AmsellemOuazana D and Bieche I: Hedgehog
pathway activation in human transitional cell carcinoma of the
bladder. Br J Cancer. 106:1177–1186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gialmanidis IP, Bravou V, Amanetopoulou
SG, Varakis J, Kourea H and Papadaki H: Overexpression of hedgehog
pathway molecules and FOXM1 in non-small cell lung carcinomas. Lung
Cancer. 66:64–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bourboulia D and Stetler-Stevenson WG:
Matrix metalloproteinases (MMPs) and tissue inhibitors of
metalloproteinases (TIMPs): Positive and negative regulators in
tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bourdeanu L and Luu T: J Adv Pract Oncol.
5:246–260. 2014.PubMed/NCBI
|
|
51
|
Wainberg ZA and Drakaki A: The importance
of optimal drug sequencing in metastatic colorectal cancer:
Biological rationales for the observed survival benefit conferred
by first-line treatment with EGFR inhibitors. Expert Opin Biol
Ther. 15:1205–1220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wen N, Wang Y, Wen L, Zhao SH, Ai ZH, Wang
Y, Wu B, Lu HX, Yang H, Liu WC and Li Y: Overexpression of FOXM1
predicts poor prognosis and promotes cancer cell proliferation,
migration and invasion in epithelial ovarian cancer. J Transl Med.
12:1342014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cui D, Chen X, Yin J, Wang W, Lou M and Gu
S: Aberrant activation of Hedgehog/GLI1 pathway on angiogenesis in
gliomas. Neurol India. 60:589–596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen JS, Huang XH, Wang Q, Huang JQ, Zhang
LJ, Chen XL, Lei J and Cheng ZX: Sonic hedgehog signaling pathway
induces cell migration and invasion through focal adhesion
kinase/AKT signaling-mediated activation of matrix
metalloproteinase (MMP)-2 and MMP-9 in liver cancer.
Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hwang J, Kang MH, Yoo YA, Quan YH, Kim HK,
Oh SC and Choi YH: The effects of sonic hedgehog signaling pathway
components on non-small-cell lung cancer progression and clinical
outcome. World J Surg Oncol. 12:2682014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Moeini A, Cornellà H and Villanueva A:
Emerging signaling pathways in hepatocellular carcinoma. Liver
Cancer. 1:83–93. 2012. View Article : Google Scholar : PubMed/NCBI
|
